Community Pharmacy England is once again leading the organisation of a joint Parliamentary drop-in event with fellow primary care bodies, continuing a long-running collaborative partnership. Following on from last year’s successful joint event, the 2026 iteration, ‘Future of Primary Care’, will be held in January and is being co-hosted with the British Dental Association, British
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Amiodarone 100mg and 200mg tablets MSN/2025/056 Tier 2 – medium impact Date of issue: 20th May 2025 Amiodarone 100mg and 200mg tablets are in limited supply until w/c 17 November 2025 Amiodarone suspension remains available (Specials). Unlicensed imports of amiodarone 100mg
Read moreThe Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers MSN/2025/057 Tier 2 – medium impact Date of issue: 20/10/2025 Mometasone (Asmanex Twisthaler®) 200microgram/dose dry powder inhaler (60 dose) is being discontinued from late October 2025.
Read moreCommunity pharmacy owners are being asked to share their views and concerns as we head into winter, as well as any further feedback they have, before the next full Community Pharmacy England Committee meeting taking place in November. As pharmacy owners brace themselves for what is expected to be another challenging winter across the NHS,
Read moreThe Department of Health and Social Care (DHSC) has today (16/10/2025) confirmed the following initial list of price concessions for October 2025: Drug Pack size Price concession Amiodarone 100mg tablets 28 £2.74 Amiodarone 200mg tablets 28 £6.05 Co-careldopa 12.5mg/50mg tablets 90 £5.97 Co-careldopa 25mg/100mg tablets 100 £8.38 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.80 Dutasteride
Read moreCommunity Pharmacy England will be holding a webinar about the new hub and spoke dispensing regulations on Wednesday 29th October at 7pm. Regulations permitting hub and spoke dispensing between different retail pharmacy business came into effect earlier this month The new provisions enable all pharmacies to have hub and spoke arrangements, subject to certain requirements
Read moreWith negotiations on the 2026/27 Community Pharmacy Contractual Framework (CPCF) expected to begin this autumn, Community Pharmacy England CEO Janet Morrison gave an important sector update at this week’s Pharmacy Show. Janet delivers her keynote speech Janet outlined how Community Pharmacy England has been preparing for the upcoming CPCF negotiations and working to drive better
Read moreThe Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted.
Read moreThe Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Dalivit® Oral Drops MSN/2025/055 Tier 2 – medium impact Date of issue: 15/10/2025 Dalivit® Oral Drops are out of stock until further notice. Abidec® Multivitamin Drops remain available and can support increased demand. A copy of this
Read moreCommunity Pharmacy England met in London in September, with Members considering strategy and tactics ahead of upcoming CPCF negotiations, alongside other important matters. The work that has been undertaken by Community Pharmacy England since the 2025/26 funding negotiations concluded has been of critical importance for the sector. Not only has there been a huge programme
Read more
